|
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
PROLOGUERisk In Health Care: Case StudiesWhen Daniel Kahneman and Amos Tversky shared their findings in the 1970s about how human beings evaluate information and make decisions, they enlightened the field of economics and spawned the field of behavioral economics. No longer—if ever he was—solely a rational actor directly motivated by his own self-interest, man was found to be both more complex and more limited. It turns out that human beings make decisions that are often illogical, that do not maximize their economic interests, or that even, in some cases, result in the best health outcomes possible. In hindsight, some of these findings seem to confirm the obvious—for example, that people dont always behave rationally, and that one persons "rational" is anothers "crazy." Knowing that individuals sometimes act in their own best interest and sometimes act in ways that seem to undermine their own success, do policymakers have an obligation to direct individuals behavior toward some established ideal that will optimize the chances of individuals success? Should information be communicated and decisions framed in ways that will maximize specific desired outcomes? If so, how is this best achieved? Or should policymakers endeavor to educate and inform people and then respect the decisions that they make, even if some would regard the outcomes as less than optimal? The case studies that follow present findings of efforts at the federal and individual levels to influence treatment decisions using different incentives and information. In the first, Jennifer Polinski, Philip Wang, and Michael Fischer (of Brigham and Womens Hospital in Boston, Massachusetts, and the National Institute of Mental Health in Bethesda, Maryland) examine the effectiveness of efforts to get the word out about the elevated risks to selected patient populations of prescribing atypical antipsychotic medications. They find that Medicaid prior authorization, one tool policymakers use to shape treatment patterns, might not be nimble enough to respond to changing safety guidance. Swooping down from the broad national picture, Steven Katz and Sarah Hawley of the University of Michigan examine the decision-making challenge that confronts a patient who is diagnosed with breast cancer. What is the role of the physician in guiding, informing, and ultimately honoring the treatment decision that the patient makes? Are there ways in which respecting individual choice can be measured and reflected in the quality indicators of a given facility when the decision goes against commonly recommended best practice? Who has the ultimate right to define what is the "rational" choice?
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||